Brief: Galectin Therapeutics Enters Line Of Credit Agreement
19/12/2025 13:32
Dec 19 (Reuters) - Galectin Therapeutics Inc GALT.O: GALECTIN THERAPEUTICS INC - ENTERS LINE OF CREDIT AGREEMENT - SEC FILING GALECTIN THERAPEUTICS INC - CO SECURES $10 MILLION LINE OF CREDIT - SEC FILING Source text: [ID:n0001140361-25-046115] Further company coverage: GALT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study